Cormorant Asset Management’s Cellectar Biosciences, Inc. CLRBW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-52,999
| Closed | -$3K | – | 73 |
|
|
2019
Q2 | $3K | Hold |
52,999
| – | – | ﹤0.01% | 67 |
|
|
2019
Q1 | $5K | Hold |
52,999
| – | – | ﹤0.01% | 63 |
|
|
2018
Q4 | $3K | Hold |
52,999
| – | – | ﹤0.01% | 65 |
|
|
2018
Q3 | $4K | Hold |
52,999
| – | – | ﹤0.01% | 60 |
|
|
2018
Q2 | $10K | Hold |
52,999
| – | – | ﹤0.01% | 56 |
|
|
2018
Q1 | $6K | Hold |
52,999
| – | – | ﹤0.01% | 49 |
|
|
2017
Q4 | $5K | Hold |
52,999
| – | – | ﹤0.01% | 49 |
|
|
2017
Q3 | $8K | Hold |
52,999
| – | – | ﹤0.01% | 50 |
|
|
2017
Q2 | $12K | Hold |
52,999
| – | – | ﹤0.01% | 69 |
|
|
2017
Q1 | $20K | Hold |
52,999
| – | – | ﹤0.01% | 75 |
|
|
2016
Q4 | $10K | Hold |
52,999
| – | – | ﹤0.01% | 77 |
|
|
2016
Q3 | $13K | Hold |
52,999
| – | – | ﹤0.01% | 84 |
|
|
2016
Q2 | $29K | Buy |
+52,999
| New | +$29K | ﹤0.01% | 84 |
|